Synthetic Cell Factories Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Microbial cell factories

A

Engineering microbial cells as a platform (factory) to produce or synthesize molecules of interest from feedstocks.

  • Sustainability
  • Specificity
  • Reliability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Specificity

A
  • Traditional chemical synthesis requires lengthy schemes to produce complex molecules
  • Specialized (and sometimes expensive, toxic) catalysts are needed to achieve the desired
    stereochemistry
  • Wastage from producing stereoisomeric by-products
  • Expressing the pathway enzymes of target compounds enable the bioactive form to be produced with the correct stereochemistry
  • Reduced wastage due to by-products with the wrong stereochemistry
  • Eliminate the chance of producing toxic diastereomers or enantiomers
  • Racemic thalidomide (cancer drug) caused birth defect due to the (S)-isomer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Reliability

A

Reliability of source for important biochemicals

  • Faster production
  • Production under controlled environment
  • Not susceptible to climatic factors
  • Reduce cost of production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sustainability

A
  • Reduce reliance on fossil resources
  • Conversion of renewable feedstocks into useful compounds
  • Higher specificity than chemical synthesis
  • Create a reliable source for important chemicals
  • Reduce energy consumption
  • Reduce material cost
  • Lower cost of production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Host selection

A

Safety
* Biological safety level (BSL1), Generally Recognized as Safe (GRAS by FDA), Qualified Presumption of Safety (QPS by EFSA)

Availability of genetic parts and tools
* Promoters, RBSs, terminators, plasmids, etc.
* Genome editing tools

Source of genes
* Prokaryotic or eukaryotic

Inherent properties
* High producer of precursor or product, High tolerance to substrate/product

Common microbial hosts
* Bacteria: E. coli, Lactobacillus spp., Bacillus spp., Yeast: Saccharomyces spp., Yarrowia lipolytica, Kluyveromyces spp., Pichia pastoris
* Unconventional microbes are increasingly being used as production hosts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathway design

A

Overexpress native pathway genes
* Promoter replacement
* Additional gene copies

Heterologous pathway
* Introduce pathway genes from an organism into a selected microbial host

De novo pathways
* Pathways designed by mix-and-matching well-characterized and substrate-promiscuous enzymes from various organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Testing

A
  • Growth profile
  • Examine the effect of the pathway on cell fitness
  • Quantify production level
  • Determine the amount of product from each pathway construct
  • Metabolomics
  • Measure the level of intermediates, native metabolites and by-products produced
  • Transcriptomics
  • Determine the transcription levels of pathway genes and native genes
  • Proteomics
  • Measure the protein expression levels of pathway genes and native genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MCF system

A
  • Identify superior pathway constructs
  • Determine the good combinations of promoters, RBSs, etc., that give high production
  • Understand the metabolic flux
  • Determine the native metabolites that were affected by the pathway
  • Detect competing pathways that produce by-products
  • Observe the intermediates that accumulated to identify bottlenecks
  • Discover physiological changes
  • Verify the pathway gene expression
  • Determine the changes that the pathway impose on the transcription and protein expression of native genes
  • Discover stress response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MCF optimisation

A
  • Re-design pathway construct
  • Use stronger/weaker/inducible promoters, RBSs
  • Change gene copy number
  • Satisfy the needs of the pathway
  • Improve co-factor/precursor availability
  • Maintain redox balance
  • Delete competing pathway genes
  • Mitigate stress imposed by the pathway
  • Overexpress genes that were down-regulated by the pathway e.g. transcription factor engineering
  • Transport product out of the cell
  • Regulate pathway expression
  • Evolve or engineer strain for enhanced stress tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Production Strain construction methods

A
  1. pathway gene fragments
    * BioBricks
    * Golden Gate
    * Gibson

Pathway integration cassette
= production strain with integrated pathway

OR

Pathway plasmid
= production strain with pathway on plasmid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

vanillic acid production

A

Solution
* To decouple cell growth and protein production through the use of biosensors
* Cells would focus on growth first, before enzyme expression
* At nutrient (glucose) rich stage, cells focus on biomass accumulation, without bioconversion
* At nutrient depletion stage, cells switch mode to biotransform substrate into valuable compounds
* Maximize nutrient utilization
* Increased cell growth improves tolerance to the substrates and products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

vanillic acid substrate-sensing circuit

A
  • Lignin
     Most abundant aromatic polymer on Earth

 Constitutes 20-30 % in plants
* Ferulic acid
 Major component of lignin
 Can be converted to valuable chemicals e.g. vanillic acid

PP3359: Transcriptional repressor, derepressed by feruloyl-CoA
Pech: Feruloyl-CoA-inducible promoter
Reporter: Red fluorescence protein

  • Fluorescence was observed upon addition of ferulic acid
  • Validated that the substrate sensing circuit functions as intended
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

vanillic acid substrate and nutrient sensing circuit

A
  • Modified the substrate-sensing circuit for nutrient sensing as well
  • Control the fcs gene expression with PcsiD, a carbon starvation inducible promoter that is activated upon nutrient depletion (high cell density)
  • Nutrient-sensing unit induced fluorescence at early stationary phase
  • Fluorescence induction began later in combination with the substrate-sensing unit
  • Validated that the complete circuit is induced by substrate and upon carbon depletion
  • Replace the reporter with the pathway enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Substrate and nutrient sensing circuit benefits

A
  • Decouples cell growth and biochemical production through autonomous nutrient-and substrate-sensing
  • Improves stress response, growth & productivity
  • Achieved ~90% conversion with the complete dynamic controller
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Artemisinic acid story background

A

Artemisinic acid
 Precursor to the anti-malaria drug, artemisinin
 Artemisinin is traditionally extracted from the plant Artemisia annua
 Microbes were engineered to produce artemisinic acid to facilitate production of the anti-malaria drug
 Cut price dramatically to benefit developing countries affected by malaria

  • Foundation was laid in 2003 using E. coli (ease of manipulation)
  • Artemisinic acid biosynthesis pathway genes were not fully identified then
  • Artemisinic acid is a terpenoid produced from farnesyl pyrophosphate (FPP)
  • ADS was identified from Artemisia annua for biosynthesizing the intermediate amorpha-4,11-diene from FPP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

artemisinic acid production circuit

A

Increase FPP availability as substrate
* E. coli has a native DXP pathway for FPP production
* Difficulties in overproducing FPP due to native regulatory mechanism
* Introduced the mevalonate (MEV) pathway from S. cerevisiae
* Construct 2 plasmids for expressing MEV pathway in 2 parts

Express ADS
* Assemble ADS gene from 84 oligonucleotides (it’s 2003!)
* Construct plasmid for expressing ADS

17
Q

Artemisinic Acid testing 1

A

Evaluate toxicity of downstream MEV pathway
* Fed different concentrations of mevalonate to strains with different number of MEV pathway genes
* Obtain growth profile of the strains
-> Toxicity of MEV pathway
* IPP accumulation is toxic
* Additional MEV pathway genes relieved the toxicity

Evaluate toxicity of ADS
* Obtain growth profiles of strains with and without ADS co-expressed along the MEV pathway Toxicity of ADS
* Negligible
* ADS relieves IPP toxicity by driving the flux forward

Using a complete MEV pathway and ADS, up to 112 mg/L of amorpha-4,11-diene was produced

18
Q

Artemisinic acid enzyme discovery

A

key pathway enzymes, CYP71AV1 and CPR (redox partner)
* Microbial host was changed to the eukaryote S. cerevisiae
* Difficulties in functional expression of these enzymes in E. coli
* More industrially-relevant (not susceptible to phage)

Host engineering to increase FPP availability
* Down-regulate ERG9 (essential but competing)
* Integrate 2 copies of tHMGR
* Integrate an additional copy of ERG20
* Overexpress upc2-1 allele (activator of sterol biosynthesis)

Express ADS
* Construct plasmid for expressing ADS
Express CYP71AV1 and CPR
* Construct plasmid for expressing CYP71AV1 and CPR

19
Q

Artemisinic Acid testing 2

A

Evaluate the effects of various genomic modifications
on amorphadiene production
* Express ADS in various strains with different combinations of genomic modifications
* Measure the production of amorphadiene

Evaluate functions of CYP71AV1 and CPR
* Express the enzymes in the best
amorphadiene-producing strain
* Analyse the products formed

20
Q

Artemisinic acid production success

A

Strain engineering improved amorphadiene production
* Combining all the modifications achieved 153 mg/L amorphadiene

Validated functions of CYP71AV1 and CPR
* Verified production of artemisinic acid
* Discovered key enzymes in artemisinic acid biosynthesis
* Achieved 115 mg/L of artemisinic acid

Commercialization of artemisinic
acid bioproduction
* Amyris licensed the engineered yeast to Sanofi for artemisinic acid production
* Reduced artemisinin cost ~10x

21
Q

Production level was extremely low. What are some possible reasons for the initial poor production level?

A
  • Toxicity
  • Metabolic burden
  • Substrate competition
  • Poor enzyme expression
    (incompatible codon usage)
  • Poor enzyme expression due to incompatible codon usage
     No growth inhibition -> Not metabolic burden, toxicity
     Reduced transcription did not correspond to proportionally
    reduced expression -> Problem at translation level
  • Solution: Codon-optimize the gene sequences and synthesize
22
Q

methods to prolong culture

A
  • Feed glucose (and other nutrients)
     Supply carbon source to biosynthesise precusor and for
    growth
  • Aerate the culture
     Provide O2 for SynO activity
23
Q

There are other biofuel candidates (e.g. medium/long-chain alcohols, alkanes, alkenes) that have been produced by metabolic engineering.
These molecules have better properties than bio-ethanol to serve as biofuels (e.g. lower hygroscopicity, higher energy density). However, these products have not been commercialized as biofuels. What are some possible reasons?

A

Some possible reasons:
* Low production level
* High consumption volume; production level is unable to meet market needs
* Relatively high price of production compared to fossil resources
* Longer production time compared to oil mining
* Feedstock (e.g. sugar) may compete with food supply